| Griffithsin protects mice from genital herpes by preventing cell-to-cell spread B Nixon, M Stefanidou, PMM Mesquita, E Fakioglu, T Segarra, L Rohan, ... Journal of virology 87 (11), 6257-6269, 2013 | 142 | 2013 |
| Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety PMM Mesquita, N Cheshenko, SS Wilson, M Mhatre, E Guzman, ... The Journal of infectious diseases 200 (4), 599-608, 2009 | 139 | 2009 |
| A compartmental pharmacokinetic evaluation of long‐acting rilpivirine in HIV‐negative volunteers for pre‐exposure prophylaxis AGA Jackson, LJ Else, PMM Mesquita, D Egan, DJ Back, Z Karolia, ... Clinical Pharmacology & Therapeutics 96 (3), 314-323, 2014 | 119 | 2014 |
| Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges JM Smith, R Rastogi, RS Teller, P Srinivasan, PMM Mesquita, U Nagaraja, ... Proceedings of the National Academy of Sciences 110 (40), 16145-16150, 2013 | 115 | 2013 |
| Bacterial vaginosis and subclinical markers of genital tract inflammation and mucosal immunity AR Thurman, T Kimble, B Herold, PMM Mesquita, RN Fichorova, ... AIDS research and human retroviruses 31 (11), 1139-1152, 2015 | 110 | 2015 |
| Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism E Fakioglu, SS Wilson, PMM Mesquita, E Hazrati, N Cheshenko, JA Blaho, ... Journal of virology 82 (19), 9337-9344, 2008 | 108 | 2008 |
| Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection PMM Mesquita, R Rastogi, TJ Segarra, RS Teller, NM Torres, AM Huber, ... Journal of antimicrobial chemotherapy 67 (7), 1730-1738, 2012 | 100 | 2012 |
| A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel MJ Keller, RP Madan, NM Torres, MJ Fazzari, S Cho, S Kalyoussef, ... PloS one 6 (1), e16475, 2011 | 92 | 2011 |
| Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants PS Fletcher, GS Wallace, PMM Mesquita, RJ Shattock Retrovirology 3, 1-12, 2006 | 92 | 2006 |
| Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials MJ Keller, PMM Mesquita, NM Torres, S Cho, G Shust, RP Madan, ... PLoS One 5 (1), e8781, 2010 | 77 | 2010 |
| Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety SS Wilson, N Cheshenko, E Fakioglu, PMM Mesquita, MJ Keller, ... Antiviral therapy 14 (8), 1113-1124, 2009 | 48 | 2009 |
| Differential mechanisms of tenofovir and tenofovir disoproxil fumarate cellular transport and implications for topical preexposure prophylaxis E Taneva, K Crooker, SH Park, JT Su, A Ott, N Cheshenko, I Szleifer, ... Antimicrobial agents and chemotherapy 60 (3), 1667-1675, 2016 | 47 | 2016 |
| Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections BC Herold, PM Mesquita, RP Madan, MJ Keller American journal of reproductive immunology 65 (3), 325-333, 2011 | 46 | 2011 |
| Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections RP Madan, PMM Mesquita, N Cheshenko, B Jing, V Shende, E Guzman, ... Journal of virology 81 (14), 7636-7646, 2007 | 45 | 2007 |
| A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring MJ Keller, PM Mesquita, MA Marzinke, R Teller, L Espinoza, JM Atrio, ... Aids 30 (5), 743-751, 2016 | 44 | 2016 |
| Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics E Taneva, S Sinclair, PMM Mesquita, B Weinrick, SA Cameron, ... JCI insight 3 (13), 2018 | 41 | 2018 |
| Comparison of follicular and luteal phase mucosal markers of HIV susceptibility in healthy women AR Thurman, N Chandra, N Yousefieh, I Zalenskaya, T Kimble, S Asin, ... AIDS research and human retroviruses 32 (6), 547-560, 2016 | 38 | 2016 |
| Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety TJ Segarra, E Fakioglu, N Cheshenko, SS Wilson, PMM Mesquita, ... PloS one 6 (11), e27675, 2011 | 38 | 2011 |
| Comparison of mucosal markers of human immunodeficiency virus susceptibility in healthy premenopausal versus postmenopausal women AR Thurman, N Yousefieh, N Chandra, T Kimble, S Asin, C Rollenhagen, ... AIDS research and human retroviruses 33 (8), 807-819, 2017 | 37 | 2017 |
| Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine model PMM Mesquita, SS Wilson, P Manlow, L Fischetti, MJ Keller, BC Herold, ... Journal of Virology 82 (13), 6576-6584, 2008 | 37 | 2008 |
Patrick KiserProfessor of Biomedical Engineering, Northwestern UniversityVerified email at northwestern.edu
